Inflammation insights powered by human flare biology
Proprietary inflammasome assays to de-risk crystal disease programs, and discovery efforts.
Patient Samples
Human Flare Assay
Multi-Omics
Actionable Outputs
Patient Samples
Human Flare Assay
Multi-Omics
Actionable Outputs
Partnered Services
Run your candidates through our Flare-in-a-Dish assay and get translation-ready readouts.
- Head-to-head MoA profiling in human inflammasome models
- Biomarker discovery and responder stratification from multi-omics
Therapeutics Discovery
Internal programs in gout, CPPD disease for new therapeutics and diagnostics targets.
Leadership
Martin Williams
CEO, Co-Founder
20+ years of experience building therapeutics platforms from the ground floor. Gout patient bringing both strategic vision and lived understanding of the disease.
Prof. Tony Merriman, PhD
CSO, Co-Founder
World-leading authority on the genetic basis of inflammasome activation. Professor & Sr. Scientist, Medicine, UAB.
Ready to accelerate your crystal disease program?
Start with a conversation about your program.